Inspire Medical Systems, Inc.
INSP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,517 | $5,961 | $7,071 | $6,272 |
| - Cash | $150 | $186 | $442 | $214 |
| + Debt | $32 | $25 | $9 | $34 |
| Enterprise Value | $5,399 | $5,800 | $6,638 | $6,092 |
| Revenue | $803 | $625 | $408 | $233 |
| % Growth | 28.5% | 53.2% | 74.7% | – |
| Gross Profit | $680 | $528 | $342 | $200 |
| % Margin | 84.7% | 84.5% | 83.8% | 85.7% |
| EBITDA | $65 | -$17 | -$41 | -$39 |
| % Margin | 8.1% | -2.7% | -10% | -16.5% |
| Net Income | $54 | -$21 | -$45 | -$42 |
| % Margin | 6.7% | -3.4% | -11% | -18% |
| EPS Diluted | 1.75 | -0.72 | -1.6 | -1.54 |
| % Growth | 343.1% | 55% | -3.9% | – |
| Operating Cash Flow | $130 | $25 | $12 | -$20 |
| Capital Expenditures | -$39 | -$24 | -$9 | -$5 |
| Free Cash Flow | $91 | $1 | $2 | -$25 |